Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | smdr2 | 0.0138 | 0.0901 | 0.506 |
Loa Loa (eye worm) | hypothetical protein | 0.0137 | 0.0886 | 0.4976 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0138 | 0.0901 | 1 |
Schistosoma mansoni | spingomyelin synthetase-related | 0.0057 | 0.0098 | 0.0548 |
Trichomonas vaginalis | ABC transporter, putative | 0.0138 | 0.0901 | 1 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0138 | 0.0901 | 0.506 |
Brugia malayi | multidrug resistance protein 3 | 0.0138 | 0.0901 | 0.4774 |
Entamoeba histolytica | P-glycoprotein-2 | 0.0138 | 0.0901 | 0.0812 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0138 | 0.0901 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0121 | 0.0726 | 0.4076 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.0138 | 0.0901 | 1 |
Echinococcus multilocularis | ATP binding cassette sub family B | 0.0137 | 0.0886 | 0.4976 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.0138 | 0.0901 | 1 |
Plasmodium vivax | sphingomyelin synthase 1, putative | 0.0057 | 0.0098 | 0.1083 |
Loa Loa (eye worm) | hypothetical protein | 0.0057 | 0.0098 | 0.0548 |
Loa Loa (eye worm) | hypothetical protein | 0.0057 | 0.0098 | 0.0548 |
Trichomonas vaginalis | sphingomyelin synthetase, putative | 0.0057 | 0.0098 | 0.1083 |
Trichomonas vaginalis | ABC transporter, putative | 0.0138 | 0.0901 | 1 |
Plasmodium falciparum | sphingomyelin synthase 1, putative | 0.0057 | 0.0098 | 0.1083 |
Entamoeba histolytica | P-glyco protein 6, putative | 0.0138 | 0.0901 | 0.0812 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0138 | 0.0901 | 0.506 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0138 | 0.0901 | 1 |
Brugia malayi | Copper type II ascorbate-dependent monooxygenase, C-terminal domain containing protein | 0.0121 | 0.0726 | 0.3732 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0138 | 0.0901 | 0.506 |
Chlamydia trachomatis | ABC transporter ATP binding protein/permease | 0.0138 | 0.0901 | 0.5 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0138 | 0.0901 | 0.506 |
Loa Loa (eye worm) | ATP-binding cassette sub-family B member 2 | 0.0138 | 0.0901 | 0.506 |
Loa Loa (eye worm) | hypothetical protein | 0.0138 | 0.0901 | 0.506 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0138 | 0.0901 | 1 |
Trichomonas vaginalis | ABC transporter, putative | 0.0138 | 0.0901 | 1 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0138 | 0.0901 | 0.506 |
Echinococcus granulosus | 5'partial|ATP binding cassette sub family B | 0.0137 | 0.0886 | 0.4976 |
Loa Loa (eye worm) | hypothetical protein | 0.0057 | 0.0098 | 0.0548 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0138 | 0.0901 | 0.506 |
Trichomonas vaginalis | taga, putative | 0.0138 | 0.0901 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0138 | 0.0901 | 1 |
Echinococcus multilocularis | sphingomyelin synthase protein 1 | 0.0057 | 0.0098 | 0.0548 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0138 | 0.0901 | 1 |
Trichomonas vaginalis | sphingomyelin synthetase, putative | 0.0057 | 0.0098 | 0.1083 |
Trichomonas vaginalis | abcb9, putative | 0.0138 | 0.0901 | 1 |
Trypanosoma cruzi | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.0542 | 0.4903 | 0.5 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0138 | 0.0901 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0138 | 0.0901 | 1 |
Toxoplasma gondii | ABC transporter transmembrane region domain-containing protein | 0.0138 | 0.0901 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0057 | 0.0098 | 0.1083 |
Trichomonas vaginalis | sphingomyelin synthetase, putative | 0.0057 | 0.0098 | 0.1083 |
Entamoeba histolytica | P-glycoprotein-5 | 0.0138 | 0.0901 | 0.0812 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0138 | 0.0901 | 0.506 |
Plasmodium falciparum | sphingomyelin synthase 2, putative | 0.0057 | 0.0098 | 0.1083 |
Trichomonas vaginalis | ABC transporter, putative | 0.0138 | 0.0901 | 1 |
Leishmania major | phosphatidylcholine:ceramide cholinephosphotransferase 2 | 0.0542 | 0.4903 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0097 | 0.0487 | 0.5408 |
Loa Loa (eye worm) | hypothetical protein | 0.0057 | 0.0098 | 0.0548 |
Schistosoma mansoni | peptidylglycine monooxygenase | 0.0121 | 0.0726 | 0.4076 |
Schistosoma mansoni | dopamine-beta-monooxygenase | 0.0121 | 0.0726 | 0.4076 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0138 | 0.0901 | 1 |
Trichomonas vaginalis | hypothetical protein | 0.0057 | 0.0098 | 0.1083 |
Plasmodium falciparum | multidrug resistance protein 1 | 0.0138 | 0.0901 | 1 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0138 | 0.0901 | 0.506 |
Loa Loa (eye worm) | multidrug resistance protein 3 | 0.0138 | 0.0901 | 0.506 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0138 | 0.0901 | 1 |
Echinococcus multilocularis | peptidyl glycine alpha amidating monooxygenase | 0.0227 | 0.1781 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0227 | 0.1781 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0138 | 0.0901 | 1 |
Plasmodium vivax | multidrug resistance protein 1, putative | 0.0138 | 0.0901 | 1 |
Schistosoma mansoni | cathepsin D (A01 family) | 0.014 | 0.0914 | 0.5134 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0138 | 0.0901 | 1 |
Entamoeba histolytica | P-glycoprotein 5, putative | 0.0138 | 0.0901 | 0.0812 |
Schistosoma mansoni | multidrug resistance protein | 0.0138 | 0.0901 | 0.506 |
Loa Loa (eye worm) | hypothetical protein | 0.0057 | 0.0098 | 0.0548 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0138 | 0.0901 | 1 |
Trypanosoma cruzi | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.0542 | 0.4903 | 0.5 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0138 | 0.0901 | 0.506 |
Entamoeba histolytica | P-glycoprotein-2 | 0.0138 | 0.0901 | 0.0812 |
Trichomonas vaginalis | abcb9, putative | 0.0138 | 0.0901 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0138 | 0.0901 | 1 |
Schistosoma mansoni | peptidyl-glycine monooxygenase | 0.0227 | 0.1781 | 1 |
Entamoeba histolytica | P-glycoprotein-2, putative | 0.0138 | 0.0901 | 0.0812 |
Echinococcus granulosus | sphingomyelin synthase protein 1 | 0.0057 | 0.0098 | 0.0548 |
Brugia malayi | ABC transporter family protein | 0.0138 | 0.0901 | 0.4774 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0138 | 0.0901 | 1 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0097 | 0.0487 | 0.2737 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0138 | 0.0901 | 0.506 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0138 | 0.0901 | 0.506 |
Plasmodium vivax | sphingomyelin synthase 2, putative | 0.0057 | 0.0098 | 0.1083 |
Toxoplasma gondii | ATP-binding cassette transporter ABC.B1 | 0.0138 | 0.0901 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0138 | 0.0901 | 1 |
Mycobacterium tuberculosis | Probable transmembrane multidrug efflux pump | 0.0138 | 0.0901 | 0.5 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0138 | 0.0901 | 1 |
Brugia malayi | Copper type II ascorbate-dependent monooxygenase, C-terminal domain containing protein | 0.0059 | 0.0119 | 0.0129 |
Trichomonas vaginalis | abcb9, putative | 0.0138 | 0.0901 | 1 |
Plasmodium falciparum | sphingomyelin synthase 1, putative | 0.0057 | 0.0098 | 0.1083 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0138 | 0.0901 | 0.506 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0138 | 0.0901 | 0.506 |
Toxoplasma gondii | hypothetical protein | 0.0057 | 0.0098 | 0.1083 |
Entamoeba histolytica | P-glycoprotein-1 | 0.0138 | 0.0901 | 0.0812 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0138 | 0.0901 | 0.506 |
Schistosoma mansoni | cathepsin D (A01 family) | 0.014 | 0.0914 | 0.5134 |
Loa Loa (eye worm) | hypothetical protein | 0.0138 | 0.0901 | 0.506 |
Trichomonas vaginalis | sphingomyelin synthetase, putative | 0.0057 | 0.0098 | 0.1083 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0097 | 0.0487 | 0.2737 |
Trypanosoma brucei | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.0542 | 0.4903 | 1 |
Onchocerca volvulus | 0.0138 | 0.0901 | 0.5 | |
Brugia malayi | Copper type II ascorbate-dependent monooxygenase, C-terminal domain containing protein | 0.0227 | 0.1781 | 1 |
Trypanosoma brucei | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.0542 | 0.4903 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0138 | 0.0901 | 1 |
Schistosoma mansoni | multidrug resistance protein | 0.0138 | 0.0901 | 0.506 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0097 | 0.0487 | 0.2737 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0138 | 0.0901 | 1 |
Brugia malayi | Copper type II ascorbate-dependent monooxygenase, N-terminal domain containing protein | 0.0061 | 0.0137 | 0.0235 |
Schistosoma mansoni | multidrug resistance protein | 0.0138 | 0.0901 | 0.506 |
Echinococcus granulosus | peptidyl glycine alpha amidating monooxygenase | 0.0227 | 0.1781 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0138 | 0.0901 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0057 | 0.0098 | 0.0548 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 ratio (binding) | = 2.5 | Delta opioid activity of the compound was determined on Mouse vas deference using DADLE as standard | ChEMBL. | 8627605 |
IC50 ratio (binding) | = 2.5 | Delta opioid activity of the compound was determined on Mouse vas deference using DADLE as standard | ChEMBL. | 8627605 |
IC50 ratio (binding) | = 17.5 | Kappa opioid activity of the compound was evaluated on electrically stimulated guinea pig ileum by using ethylketazocine(EK) as standard. | ChEMBL. | 8627605 |
IC50 ratio (binding) | = 79 | Mu opioid activity of the compound was evaluated on electrically stimulated guinea pig ileum by using morphine(M) as standard. | ChEMBL. | 8627605 |
Ke (functional) | = 1.3 nM | Ke value is obtained from IC50 ratio value of the compound when compared with Opioid receptor mu 1 agonist in Guinea pig Ileum using DAMGO as radioligand | ChEMBL. | 8627605 |
Ke (functional) | = 1.3 nM | Ke value is obtained from IC50 ratio value of the compound when compared with Opioid receptor mu 1 agonist in Guinea pig Ileum using DAMGO as radioligand | ChEMBL. | 8627605 |
Ke (functional) | = 6 nM | Ke value was obtained from IC50 ratio values of the compound when compared with Opioid receptor kappa 1 agonist in Guinea pig Ileum using EK as radioligand | ChEMBL. | 8627605 |
Ke (functional) | = 6 nM | Ke value was obtained from IC50 ratio values of the compound when compared with Opioid receptor kappa 1 agonist in Guinea pig Ileum using EK as radioligand | ChEMBL. | 8627605 |
Ke (functional) | = 67 nM | Ke value is obtained from IC50 ratio values of the compound when compared with delta opioid agonists in MVD preparations using DADLE as radioligand | ChEMBL. | 8627605 |
Ke (functional) | = 67 nM | Ke value is obtained from IC50 ratio values of the compound when compared with delta opioid agonists in MVD preparations using DADLE as radioligand | ChEMBL. | 8627605 |
Ke ratio (binding) | = 4.7 | Selectivity ratio between morphine and ethylketazocine potencies in GPI and MVD preparations | ChEMBL. | 8627605 |
Ke ratio (binding) | = 52 | Selectivity ratio between DADLE and ethylketazocine potencies in GPI and MVD preparations | ChEMBL. | 8627605 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.